Range
5.28 - 5.75
Vol / Avg.
169.9K/352.7K
Div / Yield
-
52 Wk
5.23 - 20.07
Mkt Cap
240.8M
Payout Ratio
-
Open
5.55
P/E
-
EPS
-0.74
Shares
43.6M
Outstanding
43.6M
Total Float
33.3M
Sector: Health Care.Industry: Biotechnology
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-01, AVR-RD-02, AVR-RD-03, and AVR-RD-04 which are used for various diseases such as Fabry, Gaucher, Pompe, and Cystinosis.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.670-0.740 -0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Avrobio Questions & Anwsers

Q

How do I buy Avrobio (AVRO) stock?

A

You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avrobio's (AVRO) competitors?

Q

What is the target price for Avrobio (AVRO) stock?

A

The latest price target for Avrobio (NASDAQ: AVRO) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 25.00 expecting AVRO to rise to within 12 months (a possible 352.90% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avrobio (AVRO)?

A

The stock price for Avrobio (NASDAQ: AVRO) is $5.52 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Avrobio (AVRO) pay a dividend?

A

There are no upcoming dividends for Avrobio.

Q

When is Avrobio (NASDAQ:AVRO) reporting earnings?

A

Avrobio’s $Q3 earnings are confirmed for after-market on $November 4, 2021.

Q

Is Avrobio (AVRO) going to split?

A

There is no upcoming split for Avrobio.

Q

What sector and industry does Avrobio (AVRO) operate in?

A

Avrobio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.